New! Learn more about the all new DeepDyve personalized home page where you can quickly skim your favorite journals all from one place
Annals of Oncology
-
2012
-
2011
-
2010
-
2009
-
2008
-
2007
-
Volume 18
- Supplement 12 (Dec)
- Supplement 10 (Sep)
- Supplement 8 (Sep)
- Supplement 7 (Jun)
- Supplement 6 (Jun)
- Supplement 5 (Jul)
- December
- September
- July
- June
- May
- February
- Issue 12 (Dec)
- Issue 11 (Nov)
- Issue 10 (Oct)
- Issue 9 (Sep)
- Issue 8 (Aug)
- Issue 7 (Jul)
- Issue 6 (Jun)
- Issue 5 (May)
- Issue 4 (Apr)
- Issue 3 (Mar)
- Issue 2 (Feb)
- Issue 1 (Jan)
-
-
2006
-
Volume 17
- Supplement 10 (Sep)
- Supplement 8 (Jul)
- Supplement 7 (Jun)
- Supplement 5 (May)
- Supplement 4 (May)
- Supplement 2 (Apr)
- September
- July
- June
- May
- April
- Issue 12 (Dec)
- Issue 11 (Nov)
- Issue 10 (Oct)
- Issue 9 (Sep)
- Issue 8 (Aug)
- Issue 7 (Jul)
- Issue 6 (Jun)
- Issue 5 (May)
- Issue 4 (Apr)
- Issue 3 (Mar)
- Issue 2 (Feb)
- Issue 1 (Jan)
-
-
2005
-
2004
-
2003
-
2002
-
2001
-
2000
-
1999
-
1998
-
1997
-
1996
-
1995
-
1994
-
1993
-
1992
-
1991
-
1990
-
Bookmark
More Like This bsqdyFUtCB Preview Only
New drug development100ORESULTS OF A RANDOMIZED PHASE 2 STUDY OF PD 0332991, A CYCLIN-DEPENDENT KINASE (CDK) 4/6 INHIBITOR, IN COMBINATION WITH LETROZOLE VS LETROZOLE ALONE FOR FIRST-LINE TREATMENT OF ER + /HER2- ADVANCED BREAST CANCER (BC)101PSIGNIFICANT ANTITUMOR ACTIVITY IN A RANDOMIZED PHASE 2 STUDY COMPARING 2 SCHEDULES OF NKTR-102 IN PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC)102PPHASE 3 STUDY OF NKTR-102 VERSUS TREATMENT OF PHYSICIAN'S CHOICE (TPC) IN PATIENTS (PTS) WITH LOCALLY RECURRENT OR METASTATIC BREAST CANCER (MBC) PREVIOUSLY TREATED WITH AN ANTHRACYCLINE, A TAXANE, AND CAPECITABINE (ATC)103PP53 GENE THERAPY OF HUMAN BREAST CARCINOMA USING A CATIONIC NON - VIRAL VECTOR, LUMINESCENT SILICA NANOPARTICLES104PPHASE II RANDOMIZED STUDY OF PRE-OPERATIVE PF-04691502 PLUS LETROZOLE COMPARED WITH LETROZOLE (L) IN PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE EARLY BREAST CANCER (BC)105PANTIPROLIFERATIVE EFFECT OF NEW LIGNAN FROM ABIES SIBIRICA ON HORMONE-DEPENDENT BREAST CANCER CELLS IN VITRO106PEGFR INHIBITOR IN METASTATIC TRIPLE NEGATIVE BREAST CANCER107PCISPLATIN AND GEMCITABINE COMBINATION IN TRIPLE NEGATIVE BREAST CANCER: COMMUNITY HOSPITAL EXPERIENCE108PTREATMENT OF METASTATIC BREAST CANCER WITH ALTERNATIVE VINORELBINE AND GEMCITABINE
Finn, R.S.; Crown, J.P.; Boer, K.; Lang, I.; Parikh, R.J.; Breazna, A.; Ho, S.N.; Kim, S.T.; Randolph, S.; Slamon, D.J.; Awada, A.; Chan, S.; Jerusalem, G.H.M.; Coleman, R.E.; Huizing, M.T.; Mehdi, A.; O'Reilly, S.M.; Hamm, J.T.; Garcia, A.; Perez, E.; Cortes, J.; Perez, E.; Group, The BEACON Study; Rejeeth, C.; Kannan, S.; Dowsett, M.; Koehler, M.; Millham, R.; Borzillo, G.; A'Hern, R.; Pierce, K.; Barton, J.; Giorgetti, C.; Zhukova, O.S.; Shcherbakov, A.M.; Fetisova, L.V.; Kiselevskii, M.V.; Nifantiev, N.E.; Payandeh, M.; Aeinfar, M.; Zare, M.E.; Hilderson, I.; Geurs, F.J.; Criel, M.; Debrucker, P.; Bensalem, A.; Merrouche, M.; Ammari, A.; Benmerzouk, A.; Bouzid, K.
Follow Annals of Oncology , Volume 23 (suppl 2): ii43
Oxford University Press – May 1, 2012 -
Bookmark
More Like This WbB0VDkLPF Preview Only
Adjuvant medical therapy1PTRASTUZUMAB IN THE ADJUVANT SETTING: RETROSPECTIVE STUDY2PCOMPLIANCE IN ADJUVANT BREAST CANCER THERAPY3PWHICH IS YOUR CHOICE? NEOADJUVANT DOXORUBICIN AND DOXETAXEL (AD) VERSUS DOXORUBICIN, CYCLOPHOSPHAMIDE AND PACLITAXEL (ACT) IN LOCALLY ADVANCED BREAST CANCER4PANALYSIS OF THE TOXICITY AND TOLERABILITY IN ADJUVANT VINORELBINE AND EPIRUBICINE VERSUS DOXORUBICIN AND CYCLOPHOSPHAMIDE FOR TREATING NODE NEGATIVE BREAST CANCER; RANDOMIZED PHASE II TRIAL (AVIEN STUDY)5PANTI-TUMOR EFFECTS OF PHAGELYSATES OF E.COLI6PANTIOXIDANT N-ACETYLCYSTEINE INHIBITS CANCER-INDUCED OSTEOLYSIS IN MOUSE MODELS OF BREAST-TO-BONE METASTASIS7PNEOADJUVANT TRAZTUZUMAB IN LOCALLY ADVANCED BREAST CANCER IN THE MOROCCAN POPULATION
Mehenni, N.; Sami, S.; Fighir, R.; Moussei, A.; Bouzid, K.; Vetter, M.; Schmid, S.; Kilic, N.; Rochlitz, C.; Güth, U.; Kim, K.S.; Kim, K.S.; Gambashidze, K.; Khorava, P.; Azaladze, T.; Azaladze, A.; Lasareishvili, B.; Jaiani, E.; Tediashvili, M.; Pfister, W.; Blick, T.; Kok, S.F.; Waltham, M.; Rhizlane, B.; Khouchani, M.; Tahri, A.
Follow Annals of Oncology , Volume 23 (suppl 2): ii15
Oxford University Press – May 1, 2012 -
Bookmark
More Like This NG4O0gn1lg Preview Only
Loco-regional therapy65PSENTINEL NODE BIOPSY IN THE EARLY BREAST CANCER HOSPITAL COMARCAL LA LINEA66PEXCISION OF EXTRA MARGINS IN BREAST-CONSERVING SURGERY AT THE TIME OF PRIMARY OPERATION – ARE THERE ANY CLINICAL OR PATHOLOGICAL FACTORS ASSOCIATED WITH CORRECT DECISION-MAKING?67PANALYSIS OF LOCAL-REGIONAL RECURRENCE IN YOUNG WOMEN (≤ 35Y) RECEIVING MASTECTOMY FOR OPERABLE BREAST CANCER68PWHEN IS A CLOSE OR POSITIVE MARGIN FOLLOWING A MASTECTOMY AN INDICATION FOR CHEST WALL RADIOTHERAPY IN PATIENTS WITH T1N0 BREAST CANCER?69PADJUVANT POSTMASTECTOMY HYPOFRACTIONATED RADIOTHERAPY IN EGYPTIAN CANCER PATIENTS, A 2 YEARS FOLLOW-UP70PROLE OF INTERSTITIAL BRACHYTHERAPY IN EARLY STAGE BREAST CANCER71PSTUDY OF DOSE DISTRIBUTION OF TANGENTIAL BEAM INTENSITY MODULETED RADIOTHERAPY COMPARED TO TANGENTIAL BEAM 3D CONFORMAL RADIOTHERAPY OF CHEST WALL IN POST MASTECTOMY BREAST CANCER PATIENTS72PCOSMETIC RESULTS OF HIGH DOSE RATE BRACHYTHERAPY BOOST VERSUS ELECTRON BEAM BOOST IN THE TREATMENT OF EARLY BREAST CANCER73PEFFECT OF LOCAL SURGICAL TREATMENT ON SURVIVAL IN METASTATIC BREAST CANCER PATIENTS74PASSOCIATION OF SURGERY WITH IMPROVED SURVIVAL IN PATIENTS WITH METASTASES AT DIAGNOSIS OF BREAST CANCER76PWIDE LOCAL EXCISION OF BREAST CANCER UNDER LOCAL ANAESTHETIC: A TREATMENT OPTION77PHARMONIC SCALPEL VS. ELECTROCAUTERY DISSECTION IN MODIFIED RADICAL MASTECTOMY: RANDOMIZED CONTROLLED TRIAL
Brito, J.A. Diaz; Guardiola, Y. Santaella; Navarrete, S. Vasquez; Muñoz, J.A.; Garcia, M. Velasco; Cook, L.J.; Debnath, D.; Martin, T.; Karat, I.C.F.; Daoud, R.; Laidlaw, I.J.; Cook, W.A.J.; Tang, L.C.; Zhu, C.Y.; Di, G.H.; Ma, J.L.; Yang, Z.Z.; Yu, X.L.; Shao, Z.M.; Chen, J.Y.; Iganej, S.; Hastings, J.R.; Shaltout, E.A.; El Razek, E. Abd; Behera, M.K.; Dutta, S.; Singh, R.; Sharma, S.C.; Rath, G.K.; Kumbhaj, P.; Sharma, R.; Bhatnagar, A.R.; Bhatnagar, A.R.; Sharma, R.; Singh, D.P.; Sharma, O.P.; Sharma, S.; Gupta, S.; Kumbhaj, P.; Alhassanin, S.A.; Razek, E. Abdel; AlAgizy, H.; Morad, W.; Liubota, R.; Liubota, I.; Schepotin, I.; Zotov, A.; Parvaiz, A.; Isgar, B.; Khan, S.; Khan, S.; Murtaza, G.; Haroon, N.
Follow Annals of Oncology , Volume 23 (suppl 2): ii34
Oxford University Press – May 1, 2012 -
Bookmark
More Like This tIUSvs2s2y Preview Only
Biomarkers8O_PRMUCIN-1 PROTEIN AND MRNA EXPRESSION IN BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY9O_PRGENE MODULES AND PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER. A POOLED ANALYSIS10O_PRPROGNOSTIC SIGNIFICANCE OF PROGESTERONE RECEPTOR-POSITIVE TUMOR CELLS WITHIN IMMUNOHISTOCHEMICALLY-DEFINED LUMINAL A BREAST CANCER11OPROSPECTIVE COMPARISON OF RISK ASSESSMENT TOOLS IN EARLY BREAST CANCER: CORRELATION ANALYSIS FROM THE PHASE III WSG-PLAN B TRIAL12O_PRINDEPENDENT BLINDED VALIDATION OF THE GENOMIC INDEX OF SENSITIVITY TO ENDOCRINE THERAPY (SET)13O_PRTRANSLATIONAL STUDIES WITHIN THE TAMRAD RANDOMIZED GINECO TRIAL: EVIDENCE FOR TORC1 ACTIVATION MARKER AS A PREDICTIVE FACTOR FOR EVEROLIMUS EFFICACY IN METASTATIC BREAST CANCER (MBC)14O_PRBIOLOGY OF BREAST CANCER DIAGNOSED IN YOUNG WOMEN: POOLED GENE EXPRESSION ANALYSIS FROM 3522 PATIENTS15PA NOVEL RNA TEST TO GUIDE PRIMARY SYSTEMIC BREAST CANCER CHEMOTHERAPY16PMYOEPITHELIAL CONTROL OF THE INFLAMMATORY MICROENVIRONMENT PROMOTES TRANSITION OF DCIS TO INVASIVE DISEASE17PASSESSMENT OF THE INTRATUMORAL HETEROGENEITY IN METASTATIC BREAST CANCER (MBC) THROUGH THE ANALYSIS OF THE FREQUENCY OF PIK3CA MUTANT ALLELES18PRELEVANCE AND PREDICTION OF BREAST CANCER PHENOTYPE IN PRIMARY TUMOR AND ITS POSITIVE LYMPH NODES AND LATER DISEASE RECURRENCE (METASTATIC BREAST CANCER): RESULTS OF THE PRIMET-TRIAL (WSG / DETECT)19PHER2 EXTRACELLULAR DOMAIN LEVELS IN PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER EXPERIENCING DISEASE PROGRESSION: CASE-CONTROL COMPARISON OF SAMPLES FROM THE HERA STUDY20PQRT-PCR BASED DETERMINATION OF HER2 STATUS OF INVASIVE BREAST CARCINOMAS EQUIVOCAL BY BOTH IMMUNOHISTOCHEMISTRY (IHC) AND FLUORESCENCE IN SITU HYBRIDIZATION (FISH) TESTING21PMOLECULAR CHARACTERIZATION OF EARLY-STAGE HER2-OVEREXPRESSING BREAST CANCER (HER2+ BC) TREATED WITH ADJUVANT TRASTUZUMAB: IDENTIFICATION OF PROGNOSTIC GROUPS22PBCL2 NEGATIVE BREAST TUMORS BUT NOT AXILLARY LYMPH NODES PREDICT A BETTER OVERALL SURVIVAL IN PATIENTS TREATED WITH HIGHER DOSES OF EPIRUBICIN AT A MEDIAN FOLLOW-UP OF 15.6 YEARS23PEXPRESSION OF BETA-III TUBULIN, FOXO 3 PROTEIN AND DEOXYTHYMIDINE KINASE IN BREAST CANCER PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY24PPTPN9 IS A NEGATIVE REGULATOR OF HER3 PHOSPHORYLATION AND A PROGNOSTIC BIOMARKER IN HER2 POSITIVE BREAST CANCER25PA NOVEL SERUM THYMIDINE KINASE ACTIVITY (S-TK) ASSAY FOR QUANTIFICATION OF TOTAL CELL DIVISION IN MAN, WITH SPECIAL REFERENCE TO BREAST CARCINOMA26PCOST-EFFECTIVENESS REVIEW OF THE 21-GENE BREAST CANCER TEST27PQUANTITATIVE ANALYSIS BY REAL-TIME PCR FOR ESR1 GENE COPY NUMBER IN SERUM IN BREAST CANCER SAMPLES28PENRICHED MOLECULAR FUNCTION SIGNATURES IN TRIPLE NEGATIVE AND HORMONE RECEPTOR POSITIVE BREAST CANCER ASSOCIATED WITH METASTASIS29PCORRELATION OF CD10 AND EGFR EXPRESSION IN PHYLLODES TUMORS OF THE BREAST30PPROGNOSTIC IMPACT OF BASAL, MESENCHYMAL AND STEM CELL MARKERS IN BREAST CANCER31PS-VEGF (VASCULAR ENDOTHELIAL GROWTH FACTOR) AS PREDICTIVE FACTOR IN RESPONSE TO ANTHRACYCLINE BASED CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER32PAGEING BIOMARKERS IN AN ELDERLY BREAST CANCER POPULATION: CORRELATION WITH COMPREHENSIVE GERIATRIC ASSESSMENT (CGA)33PC-KIT EXPRESSION IN BREAST CARCINOMAS: CORRELATION WITH OTHER CLINICO-PATHOLOGICAL PARAMETERS34PBREAST CANCER PROFILE IN NORTHERN EGYPT. INITIAL RESULTS35PADJUVANT CHEMOTHERAPY IN NODE-NEGATIVE (N0) BREAST CANCER: ROUTINE UPA/PAI-1 DETERMINATION
Sinn, B.V.; von Minckwitz, G.; Denkert, C.; Eidtmann, H.; Darb-Esfahani, S.; Belau, A.; Kronenwett, R.; Holzhausen, H.; Mehta, K.; Loibl, S.; Ignatiadis, M.; Singhal, S.K.; Desmedt, C.; Haibe-Kains, B.; Criscitiello, C.; Andre, F.; Loi, S.; Piccart, M.; Michiels, S.; Sotiriou, C.; Prat, A.; Cheang, M.C.; Martín, M.; Carrasco, E.; Caballero, R.; Tyldesley, S.; Gelmon, K.; Bernard, P.S.; Nielsen, T.O.; Perou, C.M.; Gluz, O.; Kreipe, H.H.; Degenhardt, T.; Salem, M.; Kates, R.E.; Shak, S.; Svedman, C.; Liedtke, C.; Nitz, U.; Harbeck, N.; Karn, T.; Hatzis, C.; Symmans, W.F.; Pusztai, L.; Ruckhäberle, E.; Schmidt, M.; Müller, V.; Holtrich, U.; Rody, A.; Kaufmann, M.; Bachelot, T.; Ferrero, J.; Cropet, C.; Bourgier, C.; Abadie-Lacourtoisie, S.; Levy, C.; Legouffe, E.; Lortholary, A.; Pujade-Lauraine, E.; Treilleux, I.; Azim, H.A.; Michiels, S.; Bedard, P.L.; Singhal, S.K.; Criscitiello, C.; Ignatiadis, M.; Haibe-Kains, B.; Piccart, M.; Sotiriou, C.; Loi, S.; Trudeau, M.E.; Pritzker, L.B.; Parissenti, A.M.; Wang, X.; Zhu, M.; Guo, B.; Shepherd, L.E.; Chapman, J.W.; Pritzker, K.P.H.; Ahmed, K.O.; Allen, M.; Gomm, J.; Marshall, J.; Jones, J.L.; De Mattos-Arruda, L.; Cortes, J.; Sánchez-Pla, A.; Aura, C.; Ortega, V.; Jimenez, J.; Saura, C.; Tabernero, J.; Seoane, J.; Vivancos, A.; Wuerstlein, R.; Freudenberger, M.; Wildenburg, L.; Ortmann, M.; Liedtke, C.; Gluz, O.; Kates, R.; Fehm, T.; Nitz, U.; Harbeck, N.; Dowsett, M.; Procter, M.; de Azambuja, E.; Scullion, M.J.; Gelber, R.D.; Leyland-Jones, B.; Tubbs, R.R.; Wang, Z.; Portier, B.; Fumagalli, D.; Lambrechts, D.; Neven, P.; Vanderhaegen, J.; Claes, B.; Singhal, S.K.; Piccart, M.; Michiels, S.; Sotiriou, C.; Loi, S.; Bozovic, I.; de Azambuja, E.; Loi, S.; Ameye, L.; Piccart, M.; Chow, L.W.C.; Loo, W.T.Y.; Yip, A.Y.S.; Ong, E.Y.Y.; Ng, W.; Gijsen, M.; Tang, P.; Leung, W.Y.; Roxanis, I.; Kong, A.; Gronowitz, S.; Nisman, B.; Allweis, T.; Kadouri, L.; Mali, B.; Hamburger, T.; Peretz, T.; Pronzato, P.; Plun-Favreau, J.A.; Martinez-Galan, J.; Torres-Torres, B.; Delgado, J.R.; Núñez, M.I.; Ríos, S.; Leyland-Jones, B.; Willis, S.; Young, B.; Kim, K.S.; Zaczek, A.; Markiewicz, A.; Ahrends, T.; Nowialis, P.; Seroczynska, B.; Skokowski, J.; Szade, J.; Welnicka-Jaskiewicz, M.; Nastaly, P.; Bednarz-Knoll, N.; Arya, D.; Parikh, B.J.; Shah, P.M.; Shukla, S.N.; Patel, K.M.; Anand, A.S.; Talati, S.S.; Shah, S.A.; Patel, A.A.; Parekh, B.B.; Brouwers, B.; Hatse, S.; Corthouts, K.; Swerts, E.; Kenis, C.; Neven, P.; Christiaens, M.; Paridaens, R.; Schöffski, P.; Wildiers, H.; Ivkovic-Kapicl, T.; Djilas-Ivanovic, D.; Radovanovic, Z.; Vicko, F.; Trifunovic, J.; Hussein, O.; Abdellah, A.; Mosbah, M.; Farouk, O.; El-Saed, A.; Tubiana-Mathieu, N.; Fermeaux, V.; Saïdi, N.; Monteil, J.; Mollard, J.; Aubard, Y.; Jammet, I.; Venat-Bouvet, L.
Follow Annals of Oncology , Volume 23 (suppl 2): ii17
Oxford University Press – May 1, 2012 -
Bookmark
More Like This GVbPHIWFx7 Preview Only
Circulating tumor cells36PAUTOMATED QUANTITATIVE HER2 ASSESSMENT IN CIRCULATING TUMOR CELLS: DISCREPANCIES WITH PRIMARY TUMOR IN NEOADJUVANT AND METASTATIC TRIALS37PHER2 TUMOR HETEROGENEITY AND DISCREPANCIES IN HER2 STATUS BETWEEN PRIMARY TUMOR AND CORRESPONDING CIRCULATING TUMOR CELLS IN METASTATIC BREAST CANCER PATIENTS38PEVOLUTION OF ESTROGEN RECEPTOR (ER) AND ERBB2 EXPRESSION BETWEEN PRIMARY TUMOR AND CIRCULATING TUMOR CELLS (CTC) OF METASTATIC BREAST CANCER PATIENTS39PINVASION AND METASTASIS GENES EXPRESSION PROFILE OF CTCS-ENRICHED BLOOD SAMPLES FROM BREAST CANCER PATIENTS40PDEVELOPMENT OF CIRCULATING TUMOR CELL-ENDOCRINE THERAPY INDEX (CTC-ETI) IN METASTATIC BREAST CANCER PATIENTS41PCIRCULATING TUMOR CELLS (CTCS) AND METRONOMIC ORAL VINORELBINE (OV) IN ADVANCED BREAST CANCER (ABC) PATIENTS (PTS): EXPLORATORY PROSPECTIVE ANALYSIS
Bidard, F.; Ligthart, S.T.; Bachelot, T.; Delaloge, S.; Brain, E.; Campone, M.; Viens, P.; Pierga, J.; Terstappen, L.W.M.M.; Migliaccio, I.; Galardi, F.; Bessi, S.; Capaccioli, G.; Biagioni, C.; Truglia, M.; Santarpia, L.; Giannini, A.; Di Leo, A.; Pestrin, M.; Doisneau-Sixou, S.; Bock, C.; Kuhn, C.; Majunke, L.; Jäger, B.; Theil, C.; Jeschke, U.; Rack, B.; Markiewicz, A.; Ksiazkiewicz, M.; Seroczynska, B.; Skokowski, J.; Szade, J.; Zaczek, A.J.; Paoletti, C.; Connelly, M.C.; Chianese, D.A.; Brown, M.E.; Muñiz, M.C.; Tokudome, N.; Rae, J.M.; Thomas, D.G.; Griffith, K.A.; Hayes, D.F.; Aurilio, G.; Munzone, E.; Botteri, E.; Pedroli, S.; Sandri, M.T.; Adamoli, L.; Zorzino, L.; Sciandivasci, A.; Esposito, A.; Nolè, F.
Follow Annals of Oncology , Volume 23 (suppl 2): ii25
Oxford University Press – May 1, 2012 -
Bookmark
More Like This j8oXK7Ho4h Preview Only
Molecular biology (pre-clinical)78O_PRTHE ROLE OF AP-1 IN ENDOCRINE-RESISTANT BREAST CANCER79PIDENTIFICATION OF A BRCANESS SIGNATURE IN TRIPLE NEGATIVE BREAST CANCER BY COMPARATIVE GENOMIC HYBRIDIZATION80PEXPRESSION OF HORMAD1, A CANCER/TESTIS ANTIGEN, IN TRIPLE-NEGATIVE BREAST CANCERS WITH HIGH GENOMIC INSTABILITY81PRESPONSE TO ENDOCRINE AND TARGETED THERAPIES IN A LARGE PANEL OF PATIENT-DERIVED LUMINAL BREAST CANCER XENOGRAFTS82PERα EXPRESSION REGULATES SENSITIVITY TO PACLITAXEL IN NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER83PCORRELATION OF C-MYC WITH EPITHELIAL-MESENCHYMAL TRANSITION PHENOTYPE84PFREQUENCY OF 5382INSC AND 185DELAG MUTATION OF BRCA1 GENE: AN EXPERIENCE FROM EASTERN INDIA85PPROGNOSTIC IMPACT OF BRCA1 AND ALDH1 EXPRESSION IN SPORADIC BREAST CANCER86PTHE ROLE OF ADAM17 IN HER2 MODERATELY EXPRESSING BREAST CANCER87PLACK OF AN ASSOCIATION BETWEEN A FUNCTIONAL POLYMORPHISM IN THE SEX HORMONE-BINDING GLOBULIN (SHBG) GENE AND BREAST CANCER RISK: A META-ANALYSIS OF CASE-CONTROL STUDIES INVOLVING 23,479 SUBJECTS88PEPO-INDEPENDENT FUNCTIONAL EPO RECEPTOR IN BREAST CANCER ENHANCES ESTROGEN RECEPTOR ACTIVITY AND PROMOTES CELL PROLIFERATION89PA FEEDBACK REGULATORY LOOP BETWEEN MIR-125B AND BRMS1 LINKED TO BREAST TUMOR PROGRESSION90PIDENTIFICATION IN BREAST CANCER CELLS OF A NOVEL MECHANISM OF CSF-1R SIGNALING WHICH INVOLVES ITS NUCLEAR TRANSLOCATION AND BINDING TO THE PROMOTER OF GENES RELEVANT TO CANCER PROGRESSION91PCANCER-ASSOCIATED FIBROBLASTS INDUCE HIGH MOTILITY GROUP BOX 1 EXPRESSION IN BREAST CANCER92PTFF1 TREFOIL PROTEIN INVOLVES IN RESISTANCE TO DOXORUBICIN-INDUCED APOPTOSIS IN BREAST CANCER CELL94PCOMPARISON OF A NOVEL, LABEL-FREE, AND REAL-TIME CELL BASED SYSTEM (XCELLIGENCE) WITH A CONVENTIONAL VIABILITY ASSAY (XTT) TO DETERMINE THE ANTI-PROLIFERATIVE EFFECT OF AT-101 IN HUMAN BREAST CANCER CELLS95PCOMPARISON OF EXPRESSION LEVELS OF TWIST, SNAIL AND SLUG IN PRIMARY TUMORS AND LYMPH NODE METASTASES IN BREAST CANCER PATIENTS96PQUANTITATIVE PROTEOMICS PROFILING OF MURINE MAMMARY GLAND CELLS UNRAVELS IMPACT OF ANNEXIN-1 ON DNA DAMAGE, CELL ADHESION AND MIGRATION97PTHE ROLE OF ID PROTEINS IN THE INDUCTION OF TUMOR-INITIATING CELLS DURING PULMONARY COLONIZATION OF METASTATIC BREAST CANCER98POCTREOTIDE IN COMBINATION WITH DOCETAXEL TRIGGERS APOPTOSIS BY INDUCING SSTR2 AND SSTR5 LEVELS IN HUMAN BREAST CANCER CELLS, MCF-7 AND MDA-MB-23199PZOLEDRONIC ACID IN COMBINATION WITH SERINE/THREONINE PHOSPHATASE INHIBITORS INDUCES CYTOTOXICITY AND APOPTOSIS IN HUMAN BREAST CANCER CELLS VIA DECREASING THE ACTIVITIES OF PP1 AND PP2A
Malorni, L.; Giuliano, M.; Migliaccio, I.; Creighton, C.; Lupien, M.; Hilsenbeck, S.; Fu, X.; Trivedi, M.; Osborne, C.K.; Schiff, R.; Toffoli, S.; Bar, I.; Abdulsater, F.; Delrée, P.; Hilbert, P.; Carrasco, J.; Canon, J.; Grigoriadis, A.; Gazinska, P.; Rasmussen, M.; Isaksson, A.; de Rinaldis, E.; Mathew, S.; Marra, P.; Gillett, C.; Pinder, S.; Tutt, A.; Cottu, P.H.; Assayag, F.; Chouchane-Mlik, O.; Reyal, F.; De Cremoux, P.; Gentien, D.; Chateau-Joubert, S.; Vincent-Salomon, A.; Decaudin, D.; Marangoni, E.; Tokuda, E.; Seino, Y.; Saito, M.; Kasumi, F.; Hayashi, S.; Yamaguchi, Y.; Supernat, A.M.; Markiewicz, A.; Sejda, A.; Seroczynska, B.; Skokowski, J.; Szade, J.; Welnicka-Jaskiewicz, M.; Nastaly, P.; Bednarz-Knoll, N.; Zaczek, A.J.; Chakraborty, A.; Mukhopadhyay, A.; Bhattacharyya, D.; Choudhuri, K.; Mukhopadhyay, S.; Gangopadhyay, S.; Basak, J.; Ksiązkiewicz, M.; Zaczek, A.J.; Seroczynska, B.; Skokowski, J.; Szade, J.; Welnicka-Jaskiewicz, M.; Nastaly, P.; Bednarz-Knoll, N.; Feldinger, K.; Kerry, J.; Gijsen, M.; Murphy, G.; Kong, A.; Du, Y.; Lu, J.; Larsson, A.; Schiebel, S.; Vaapil, M.; Sun, J.; Jögi, A.; Rönnstrand, L.; Påhlman, S.; Allard, D.; Lacroix-Triki, M.; Maillot, G.; Mhamdi, L.; Pierredon, S.; Obrist, F.; Goubar, A.; Roche, H.; André, F.; Vagner, S.; Rovida, E.; Barbetti, V.; Morandi, A.; Riverso, M.; Bessi, S.; Giannini, A.; Di Leo, A.; Dello Sbarba, P.; Thuwajit, C.; Amornsupak, K.; Insawang, T.; Thuwajit, P.; Thuwajit, P.; Pelden, S.; Thuwajit, C.; Karaca, B.; Atmaca, H.; Asli, K.; Bozkurt, E.; Cakar, B.; Surmeli, Z.G.; Gursoy, P.; Karabulut, B.; Uzunoglu, S.; Sezgin, C.; Ahrends, T.; Markiewicz, A.; Nowialis, P.; Seroczynska, B.; Skokowski, J.; Szade, J.; Welnicka-Jaskiewicz, M.; Zaczek, A.J.; Swa, H.L.F.; Blackstock, W.; Lim, L.; Gunaratne, J.; Stankic, M.; Pavolvic, S.; Benezra, R.; Karaca, B.; Muslu, U.; Surmeli, Z.G.; Cakar, B.; Atmaca, H.; Asli, K.; Sezgin, C.; Uzunoglu, S.; Karabulut, B.; Uslu, R.; Surmeli, Z.G.; Gursoy, P.; Cakar, B.; Asli, K.; Atmaca, H.; Sezgin, C.; Karabulut, B.; Uslu, R.; Karaca, B.
Follow Annals of Oncology , Volume 23 (suppl 2): ii37
Oxford University Press – May 1, 2012 -
Bookmark
More Like This 8TMiT2Q1Ev Preview Only
Detection and diagnosis42PMOLECULAR PROFILES OF PRE- AND POSTOPERATIVE BREAST CANCERS REVEAL GENES THAT MAY BE DIFFERENTIALLY EXPRESSED AFTER SURGERY43PPROGNOSTIC VALUE OF DETECTION MODE IN OVER 1000 CONSECUTIVELY TREATED GRADE 2 BREAST CANCERS (BC)44PPROGNOSTIC VALUE OF DETECTION METHOD BY BREAST CANCER (BC) BY PHENOTYPE45PHR-MAS NMR SPECTROSCOPIC ASSESSMENT OF BREAST CARCINOMA TISSUES: IS IT EQUIVALENT TO HISTOPATHOLOGICAL EXAMINATION?46P3D DIGITAL BREAST TOMOSYNTHESIS: ROLE IN RECALL RATE REDUCTION IN MAMMOGRAPHY SCREENING: AN INITIAL STUDY ON ASIAN POPULATION47PFREE HAND BREAST CORE BIOPSIES IN A SELECTED GROUP ARE AS GOOD AS IMAGE GUIDED BIOPSIES48PCOMPARISON OF AN RNA-BASED MULTIGENE TEST BETWEEN CORE BIOPSIES AND CORRESPONDING SURGICAL BREAST CANCER SECTIONS49PCOST-EFFECTIVENESS EVALUATION OF THE 21-GENE BREAST CANCER TEST IN FRANCE50PSILVER-ENHANCED IN SITU HYBRIDIZATION AS AN ALTERNATIVE TO FLUORESCENCE IN SITU HYBRIDIZATION FOR ASSAYING HER2 AMPLIFICATION IN CLINICAL BREAST CANCER51PMULTIPLE PRIMARY NEOPLASIA, OR A NEOPLASIA WITH SATELLITES? THE ROLE OF MOLECULAR BIOLOGY IN THE DIAGNOSTIC PROCESS52PBREAST CANCER STEM CELLS: A NOVEL THERAPY FOR BREAST CANCER53PCLAUDINS EXPRESSION IN BREAST CANCER: HIGH OR LOW, WHAT TO EXPECT?54PBIOPSIES OF RECURRENT BREAST CANCER INCREASE THE USE OF TARGETED TREATMENT55PPROGNOSTIC ROLE OF PALPABILITY IN SCREEN DETECTED BREAST CANCER (BC)56PPREDICTORS OF AXILLARY LYMPH NODE METASTASES IN WOMEN WITH BREAST CANCER57PVALIDATION OF THREE BREAST CANCER NOMOGRAMS FOR PREDICTING THE NON-SENTINEL LYMPH NODE METASTASES AND A NEW FORMULA FOR PREDICTING NON-SENTINEL LYMPH NODE STATUS. (SECOND STUDY FROM TURKEY-FIRST UNICENTER STUDY)58PDETECTION OF HUMAN PAPILLOMAVIRUS AND EPSTEIN-BARR VIRUS IN BREAST CANCER59PMAMMARY DUCT ENDOSCOPY WITH SALINE LAVAGE FOR BREAST CANCER PREVENTION AND HOMEOSTASIS MAINTENANCE IN MIDDLE AGED WOMEN
Riis, M.L.; Kristensen, V.N.; Bukholm, I.R.; Luders, T.; Brouckaert, O.; Van Calster, B.; Van Hoorde, K.; Van Limbergen, E.; Wildiers, H.; Van Ongeval, C.; Van Steen, A.; Vergote, I.; Christiaens, M.; Neven, P.; Brouckaert, O.; Schoneveld, A.; Truyers, C.; Kellen, E.; Vergote, I.; Van Ongeval, C.; Van Steen, A.; Van Limbergen, E.; Christiaens, M.; Neven, P.; Raj, A.; Sonkar, A.A.; Kumar, J.; Kushwaha, J.K.; Shimpi, T.R.; Reynolds, V. Baksa; Teh, H.S.; Parvaiz, A.; Ismail, A.; Richardson, C.; Isgar, B.; Brase, J.C.; Müller, B.M.; Haufe, F.; Weber, K.E.; Budzies, J.; Petry, C.; Prinzler, J.; Kronenwett, R.; Dietel, M.; Denkert, C.; Rouzier, R.; Chereau, E.; Laas, E.; Genin, A.; Bendifallah, S.; Gligorov, J.; Han, S.; Kim, J.S.; Gwak, G.; Park, K.; Deme, D.; Székely, C.; Bishr, A.M.; Szllsi, Z.; Nizar, J.; Kovács, L.; Micsik, T.; Jóri, B.; Peták, I.; Telekes, A.; Gangopadhyay, S.; Mukhopadhyay, S.; Dasgupta, S.; Hor, P.; Roy, U.K.; Sengupta, S.; Basak, J.; Mukhopadhyay, A.; Ricardo, S.; Gerhard, R.; Schmitt, F.; Paredes, J.; Hilderson, I.; Geurs, F.J.; Demetter, P.; Criel, M.; Brouckaert, O.; Truyers, C.; Kellen, E.; Schoneveld, A.; Vergote, I.; Wildiers, H.; Moerman, P.; Christiaens, M.; Van Limbergen, E.; Neven, P.; Rodionova, M.; Rodionov, V.; Derici, S.Z.; Sevinc, A.I.; Harmancioglu, O.; Saydam, S.; Kocdor, M.A.; Canda, T.; Fard, Z. Tahmasebi; Xu, Z.; Dou, C.; Dou, T.; Gu, Y.; Wu, S.; Song, Y.; Xing, H.
Follow Annals of Oncology , Volume 23 (suppl 2): ii27
Oxford University Press – May 1, 2012 -
Bookmark
More Like This 4JxYJrcHab Preview Only
Imaging60OASSESSMENT OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY WITH HIGH RESOLUTION MRI AT 3T: CORRELATION WITH PATHOLOGICAL RESPONSE61OASSESSMENT OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY WITH DIFFUSION WEIGHTED IMAGING AT 3T62P89ZR-BEVACIZUMAB PET IMAGING IN PRIMARY BREAST CANCER63PASSESSMENT OF SUNITINIB THERAPY USING AN INTEGRATED MICRO-ULTRASOUND AND PHOTOACOUSTIC SYSTEM IN MOUSE BREAST CANCER64PMAMMOGRAPHY AND ULTRASONOGRAPHY REPORTS COMPARED WITH TISSUE DIAGNOSIS: AN EVIDENCE-BASED STUDY, IRAN, 2010
Pinker-Domenig, K.; Bickel, H.; Bogner, W.; Dubsky, P.; Bago-Horvath, Z.; Rudas, M.; Helbich, T.; Pinker-Domenig, K.; Bickel, H.; Bogner, W.; Dubsky, P.C.; Rudas, M.; Bago-Horvath, Z.; Helbich, T.; Gaykema, S.B.M.; Brouwers, A.H.; Timmer-Bosscha, H.; Lub-de Hooge, M.N.; van der Meulen, S.; Bart, J.; Jansen, L.; de Vries, J.; de Vries, E.G.E.; Schröder, C.P.; Sun, J.; Yin, M.; Heinmiller, A.; McGrath, T.; Bates, D.; Needles, A.; Theodoropoulos, C.; Foster, S.; Akbari, M.; Khayamzadeh, M.; Haghighatkhah, H.; Shafiee, M.
Follow Annals of Oncology , Volume 23 (suppl 2): ii32
Oxford University Press – May 1, 2012 -
Bookmark
More Like This 5B96IkZIY6 Preview Only
Miscellaneous109PUPDATED RESULTS OF THE BOLERO-2 PHASE III TRIAL EVALUATING EVEROLIMUS (EVE) FOR POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER (ABC)110PCHANGES OF SERUM VITAMIN D ACCORDING TO THE BREAST CANCER TREATMENT112PQUALITY OF LIFE AMONG BREAST CANCER PATIENTS IN YEMEN116PESTIMATION OF BREAST CANCER BURDEN IN IRAN AND ITS COMPARISON WITH EASTERN MEDITERRANEAN REGION AND THE WORLD117PINITIALLY METASTATIC VERSUS RECURRENT BREAST CANCER: IS THERE ANY DIFFERENCE?118PFATIGUE AS A CAUSE OF SEXUAL PROBLEMS IN BREAST CANCER PATIENTS119PEVOLUTION AND LANDSCAPE OF CLINICAL TRIALS FOR BREAST CANCER PATIENTS120PBREAST CANCER AND DIABETES: RETROSPECTIVE STUDY121PBRAIN METASTASIS AND HER-2 STATUS IN METASTATIC BREAST CANCER (MBC) IN OMAN122PBREAST CANCER METASTASES TO THE GYNECOLOGICAL ORGANS AND PERITONEUM: A SINGLE INSTITUTION EXPERIENCE123PARE WE STARVING OUR ELECTIVE PATIENTS FOR TOO LONG? A CLINICAL AUDIT124PCLINICOPATHOLOGIC CHARACTERISTICS OF BREAST CANCER IN YOUNGER WOMEN RESULTS OF AN ANALYSIS OF 219 CASES FROM A SINGLE INSTITUTION125PCOMMUNITY THERAPY BY EARLY BREAST CANCER DETECTION AND ITS PREVENTION BY LIFESTYLE MODIFICATION126PDETERMINING THE INCIDENCE AND RISK FACTORS OF LYMPHEDEMA IN BREAST CANCER PATIENTS127PBREAST CANCER AND ACUTE LEUKEMIA128PEFFECT OF THE COMBINATION OF POLYUNSATURATED FATTY ACID O3 AND CHEMOTHERAPY IN BREAST CANCER CELL LINES129PLAPATINIB IN HER2 POSITIVE METASTATIC CARCINOMA BREAST130PBREAST CANCER (BC) IN MARTINIQUE, CLINICAL AND PATHOLOGICAL CHARACTERISTICS (PRELIMINARY RESULTS)131PASSOCIATION OF HLA CLASS I AND CLASS II ALLELES WITH BREAST CANCER IN EASTERN INDIAN POPULATION132PSO THE LAST SHALL BE FIRST AND THE FIRST SHALL BE LAST*
Rugo, H.; Piccart, M.; Hortobagyi, G.; Noguchi, S.; Gnant, M.; Campone, M.; Bauly, H.; Mukhopadhyay, P.; Sahmoud, T.; Baselga, J.; Kim, H.J.; Ahn, S.H.; Ali, M.M.S.; Khayamzadeh, M.; Salmanian, R.; Aboulhasani, F.; Moradi, M.; Akbari, M.; Mansour, O.M.; El-Kholy, M.M.; Salem, S.E.; Darweesh, A.D.; El-Gammal, M.M.; Aly-Eldin, N.H.; Cidón, E. Uña; Dogan, S.; Goubar, A.; Arnedos, M.; Delaloge, S.; André, F.; Mehenni, N.; Gamaz-Bensaou, M.; Sami, S.; Bouzid, K.; Monem, E. Abdul; Mehdi, I.; Al Bahrani, B.; Tomasevic, Z.; Milovic, M.; Tomasevic, Z.; Milovanovic, Z.; Fussey, J.M.; Parvaiz, A.; Allan, A.; Mohammed, J.; Isgar, B.; Abdelrhman, O.M.; Koner, S.; Basak, J.; Chakraborty, A.; Majumder, D. Bhattacharya; Dasgupta, S.; Das, P.; Pal, N.; Sen, S.; Mukhopadhyay, S.; Mukhopadhyay, A.; Makhdoumi, Y.; Delgosha, M. Soltani; Zolfaghari, M.; Ramadan, S.M.; Fouad, T.M.; Lo-Coco, F.; Damasco-Avila, E.; Ibarra-Sánchez, M.; Esparza-López, J.; García, L.; Zentella, A.; Behera, M.K.; Sharma, A.; Shukla, P.; Julka, P.K.; Rath, G.K.; Bera, O.; Dieye, M.; Malsa, S.; Ekindi, N.; Baudin, J.; Grossat, N.; Dorival, M.; Tossen, G.; Dasgupta, S.; Mukhopadhyay, S.; Basak, J.; Chakraborty, A.; Majumder, D. Bhattacharya; Gangopadhyay, S.; Mukhopadhyay, A.; Parvaiz, A.; Allan, A.; Dhillon, S.; Isgar, B.
Follow Annals of Oncology , Volume 23 (suppl 2): ii46
Oxford University Press – May 1, 2012
© 2012 DeepDyve, Inc. All rights reserved.
Terms of Service | Privacy Policy
